U.S. Physical Therapy (USPH)
(Delayed Data from NYSE)
$88.68 USD
+0.96 (1.09%)
Updated Oct 13, 2025 03:58 PM ET
After-Market: $88.96 +0.28 (0.32%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
USPH 88.68 +0.96(1.09%)
Will USPH be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for USPH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for USPH
ELAN or USPH: Which Is the Better Value Stock Right Now?
ASTH vs. USPH: Which Stock Is the Better Value Option?
USPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
ASTH or USPH: Which Is the Better Value Stock Right Now?
Does U.S. Physical Therapy (USPH) Have the Potential to Rally 26.48% as Wall Street Analysts Expect?
U.S. Physical Therapy (USPH) Tops Q2 Earnings and Revenue Estimates
Other News for USPH
USPH forms Non-ADX 1,2,3,4 Bullish on October 10
Is USPH primed for volatility? NR7 shows up after sinking 1.68%
Is USPH building pressure? NR7 shows up after gaining 0.68%
USPH Dividend Yield Pushes Above 2%
Is USPH ready to move higher? New Uptrend shows up after rising 0.27%